8.11
-0.19 (-2.23%)
| Penutupan Terdahulu | 8.30 |
| Jumlah Dagangan | 80,977 |
| Purata Dagangan (3B) | 436,782 |
| Modal Pasaran | 479,950,880 |
| Harga / Jualan (P/S) | 9.19 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2026 |
| Margin Keuntungan | -34.76% |
| Margin Operasi (TTM) | -31.56% |
| EPS Cair (TTM) | -0.300 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 21.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 45.14% |
| Nisbah Semasa (MRQ) | 3.56 |
| Aliran Tunai Operasi (OCF TTM) | -5.57 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.06 M |
| Pulangan Atas Aset (ROA TTM) | -8.96% |
| Pulangan Atas Ekuiti (ROE TTM) | -24.12% |
Sentimen Berita
AISkor Stockmoo
| Nilai 38% | -0.3 |
| Hutang rendah. Keuntungan lemah. Kecairan jangka pendek mencukupi. Aliran tunai negatif. info | |
| Daripada penilaian laporan AI Insight kami tentang pulangan dijangka berbanding risiko. info | NA |
| Penilaian Relatif info | NA |
| Pertumbuhan Tersirat info | NA |
| Sejarah Penilaian info | NA |
| Pulangan atas Modal info | NA |
| Nilai Pegangan info | NA |
| Premium Risiko info | NA |
| Penilaian Pasaran info | NA |
| Masa 38% | 1.6 |
| Aliran menaik sepanjang tahun lalu. Agak di bawah paras tertinggi 52 minggu. info | |
| Aliran menaik, tetapi purata bergeraknya telah mendatar. Harga hampir dengan purata itu. Dagangan lebih tinggi pada hari harga naik. info | |
| Daripada analisis teknikal AI kami terhadap carta. info | NA |
| Sentimen 25% | 1.0 |
| Tiada harga sasaran terkini, jadi berdasarkan arah semakan harga sasaran. info | |
| Berita terkini kebanyakannya positif. info | |
| Sentimen Pegangan info | NA |
| Wang Pintar | NA |
| Aktiviti Orang Dalam info | NA |
| Aliran Institusi info | NA |
| Kedudukan Jual Singkat info | NA |
| Keadaan pasaran dan sektor lemah. | |
| Persekitaran pasaran berhati-hati. info | |
| Sektor mengatasi prestasi pasaran. | |
| Tonggak-tonggak sependapat, jadi skor diperkukuh. | |
| Tidak dikira dalam skor | |
| Perolehan sesaham turun naik. Mencatat kerugian dalam tahun-tahun kebelakangan. info | |
| Corak pembalikan menaik baru-baru ini: Engulfing menaik. info | |
| Di atas garis aliran jangka sederhana. info | |
| Harga tinggi berbanding purata 52 minggunya. Turun dalam tempoh 5 tahun. info | |
| Momentum jangka pendek meningkat. info | |
| Harga di antara sokongan dan rintangan. info | |
| Skor Akhir | 0.79 |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Alpha Teknova, Inc. | Bercampur | Bercampur |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B | Skor |
|---|---|---|---|---|---|
| TKNO | 480 M | - | - | - | 0.8 |
| SUPN | 6 B | 27.84% | - | 1.59 | -1.0 |
| ANIP | 2 B | - | 13.74 | 2.57 | -0.1 |
| COLL | 783 M | - | 23.13 | 2.72 | 0.1 |
| AQST | 435 M | - | - | - | -1.7 |
| TLRY | 279 M | - | - | 0.200 | -2.2 |
|
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 7.95% |
| % Dimiliki oleh Institusi | 76.88% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 05 Nov 2026 | Yahoo Finance |
Alpha Teknova Inc (TKNO) (Q3 2026) Earnings Call Highlights: Record Revenue, Surging Clinical ...
Alpha Teknova Inc (TKNO) posted record Q3 2026 revenue of $12.2 million, up 22% year-over-year, as Clinical Solutions jumped 86% and gross margin expanded to 38.0%. |
| 05 Nov 2026 | Yahoo Finance |
Alpha Teknova (TKNO) Q3 2026 Earnings Call Transcript
Biopharma demand lifted results and a $46 million raise bolstered the balance sheet. |
| 05 Nov 2026 | Yahoo Finance |
Alpha Teknova Q3 Earnings Call Highlights
Alpha Teknova (NASDAQ:TKNO) raised its 2026 revenue guidance after reporting a second consecutive quarter of record revenue, as demand for custom products from biopharma, life science tools and diagnostics customers helped drive 22% year-over-year growth. The company now expects full-year revenue o… |
| 04 Nov 2026 | Yahoo Finance |
Alpha Teknova (TKNO) Reports Q3 Loss, Tops Revenue Estimates
Alpha Teknova (TKNO) delivered earnings and revenue surprises of 0.00% and +8.58%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock? |
| 04 Nov 2026 | Yahoo Finance |
Alpha Teknova: Q3 Earnings Snapshot
(TKNO) on Wednesday reported a loss of $3.The Hollister, California-based company said it had a loss of 6 cents per share. |
| 04 Nov 2026 | Yahoo Finance |
Teknova Reports Third Quarter 2026 Financial Results
Third quarter 2026 total revenue was $12.7 million, up 22% over the same quarter prior yearCompany raises 2026 revenue guidance to $46-48 millionStrengthened balance sheet with $46 million public equity offering completed in October 2026 HOLLISTER, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Alpha… |
| 30 Oct 2026 | Yahoo Finance |
Full-Year Revenue Guidance Hike Drove Alpha Teknova (TKNO) Higher
Conestoga Capital Advisors, an asset management company, released its third-quarter 2026 investor letter. The letter can be downloaded here. Conestoga Capital Advisors released its third-quarter 2026 investor letter, outlining a shifting macroeconomic backdrop for small-cap equities. After a strong… |
| 23 Oct 2026 | Yahoo Finance |
Alpha Teknova (TKNO) Stock Jumps 5.1%: Will It Continue to Soar?
Alpha Teknova (TKNO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. |
| 21 Oct 2026 | Yahoo Finance |
Teknova to Report Third Quarter 2026 Financial Results on November 4, 2026
HOLLISTER, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report… |
| 20 Oct 2026 | Yahoo Finance |
Teknova Announces Pricing of $40 Million Public Offering of Common Stock
HOLLISTER, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced the pricing of its underwritten… |
| 20 Oct 2026 | Yahoo Finance |
Alpha Teknova stock tumbles on public offering announcement
Investing.com -- Alpha Teknova Inc (NASDAQ:TKNO) shares fell 22.3% in after-hours trading Tuesday following the company's announcement of an underwritten public offering of its common stock. |
| 20 Oct 2026 | Yahoo Finance |
Teknova Announces Proposed Public Offering of Common Stock
HOLLISTER, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that it has commenced an… |
| 20 Oct 2026 | Yahoo Finance |
Teknova Announces Preliminary Third Quarter Financial Results
HOLLISTER, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced in conjunction with its filing… |
| 02 Oct 2026 | Yahoo Finance |
Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System
Developers of advanced therapies using PluriFreeze during preclinical stages can seamlessly scale to clinical manufacturing and cross-reference the Drug Master File in FDA submissionsHOLLISTER, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Pluristyx… |
| 01 Oct 2026 | Yahoo Finance |
All You Need to Know About Alpha Teknova (TKNO) Rating Upgrade to Buy
Alpha Teknova (TKNO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). |
| 22 Sep 2026 | Yahoo Finance |
Alpha Teknova (TKNO) Moves 7.1% Higher: Will This Strength Last?
Alpha Teknova (TKNO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. |
| 16 Sep 2026 | Yahoo Finance |
Teknova Expands Custom Manufacturing with Fill-Tek™ Dispensing System for Flexible Single-Use Bag Filling
Available now, this new proprietary dispensing capability lets customers order the exact single-use bag sizes and quantities their process requires, released as a single lot with one Certificate of Analysis, with no added turnaround timeHOLLISTER, Calif., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Alpha… |
| Papar semua | ||
Isyarat Terkini corak lilin dan silang EMA
Persediaan Teknikal Sederhana
AI Analisis Teknikal
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |